Vorasidenib Significantly Improves PFS in Grade 2 Gliomas Wi

Current standard of care gives 2 poor options to patients, neither of which cure grade 2 gliomas.

Related Keywords

United States , American , Ingok Mellinghoff , , World Health Organization , Department Of Neurology , American Society Of Clinical Oncology , Oncology At Memorial Sloan Kettering Cancer Center , Evnin Family Chair , Memorial Sloan Kettering Cancer Center , American Society , Clinical Oncology ,